Please provide your email address to receive an email when new articles are posted on . Dextromethorphan-bupropion significantly improved symptoms for those with major depressive disorder compared ...

Managed care organizations must prioritize dextromethorphan-bupropion based on sustained efficacy, improved remission rates, ...

The FDA approved combination dextromethorphan and bupropion extended-release tablets (Auvelity) for adults with major depressive disorder (MDD), Axsome Therapeutics announced on Friday.

Auvelity (dextromethorphan/bupropion) is a prescription oral tablet used to treat major depressive disorder (depression) in adults. It treats depression by affecting ...

An ingredient in many over-the-counter cough suppressants seems to improve the release of insulin in humans, a discovery that may lead to new treatments for Type 2 diabetes. Doctors at Heinrich Heine ...

The U.S. Food and Drug Administration (FDA) has approved Axsome Therapeutics’ (NASDAQ:AXSM) lead asset AUVELITY (dextromethorphan HBr -bupropion HCl) extended-release tablets for the treatment of ...

Gainesville, FL - Temporal summation of repeated pain stimuli, also known as "windup" pain, is mediated by N-methyl-D-aspartate (NMDA) receptors, and this pathway has long been suspected of ...

WASHINGTON U.S. Reps. Fred Upton, R-Mich., and Rick Larsen, D-Wash. earlier this week re-introduced legislation, the Dextromethorphan Distribution Act, that would restrict the distribution of raw ...

WASHINGTON Sen. Joseph Biden, Jr., D-Del., on Wednesday introduced the Dextromethorphan Abuse Reduction Act of 2007, legislation aimed to curb the rise in medicine abuse, including the misuse of cough ...